EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies

Francis Ayimbila, Kamonrat Phopin, Waralee Ruankham, Ratchanok Pingaew, Supaluk Prachayasittikul, Virapong Prachayasittikul, Tanawut Tantimongcolwat

European Journal of Pharmaceutical Sciences · 2025-01 · 204 · 106961

DOI: 10.1016/j.ejps.2024.106961 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2025-01. Verfasst von Francis Ayimbila und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700 Thailand. Hauptthemen laut MEDLINE: Sulfonamides, Serum Albumin, Human, Molecular Docking Simulation, Benzenesulfonamides. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mahidol University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

4-Bromo-N-(thiazol-2-yl)benzenesulfonamide (1) is enriched with bioactive components and is highlighted for its pharmacological properties. However, its pharmacokinetic characteristics are yet to be reported. The interaction of compound 1 with carrier proteins in the bloodstream is an important factor that affects its potential therapeutic efficacy. This study aimed to elucidate the pharmacokinetic mechanisms of compound 1 in relation to human serum albumin (HSA) using multi-spectroscopic and computational techniques. Its predicted drug-like properties revealed no mutagenicity, although potential hepatotoxicity and interactions with certain cytochrome P450 enzymes were observed. Spectroscopic analyses extensively provided the interaction between HSA and 1 through a static fluorescence quenching mechanism with spontaneous hydrophobic interactions and hydrogen bonding. The binding constant of the HSA‒1 complex was relatively moderate to strong at a level of 106 M-1. Various spectroscopic techniques including ultraviolet-visible, Fourier transform infrared, and circular dichroism spectroscopies indicated that its binding induced alteration in the α-helix content of HSA. Competitive binding and molecular docking studies designated the preferential binding of 1 to sub-structural domain IIA binding site I of HSA. Molecular dynamic simulations further illustrated the formation of a stable complex between 1 and HSA, accompanied by conformational changes in the protein. Importantly, esterase capacity of the HSA‒1 complex increased compared to the free HSA. Therefore, elucidation of the HSA‒1 binding mechanism provides valuable insights into the pharmacokinetics, suggesting potential benefits for the further development of 1 as a therapeutic agent.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SulfonamidesSerum Albumin, HumanMolecular Docking SimulationBenzenesulfonamidesProtein BindingHumansCircular DichroismSpectrometry, FluorescenceSpectroscopy, Fourier Transform InfraredThiazolesHydrophobic and Hydrophilic Interactions

Stichwörter der Autor:innen

AminothiazoleHuman serum albuminMulti-spectroscopyPharmacokineticsSulfonamide

Substanzen

SulfonamidesSerum Albumin, HumanBenzenesulfonamidesThiazoles

Autor:innen und Institutionen

  • Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700 Thailand.
  • Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700 Thailand; Department of Clinical Microbiology and Applied Technology, Faculty of Medical Techno…
  • Department of Chemistry, Faculty of Science, Srinakharinwirot University, Bangkok 10110 Thailand.
  • Department of Clinical Microbiology and Applied Technology, Faculty of Medical Technology, Mahidol University, Bangkok 10700 Thailand.
  • Center for Research Innovation and Biomedical Informatics, Faculty of Medical Technology, Mahidol University, Bangkok 10700 Thailand. Electronic address: tanawut.tan@mahidol.ac.th.

Förderung

  • Mahidol University

Zitieren

APA

Ayimbila, F., Phopin, K., Ruankham, W., Pingaew, R., Prachayasittikul, S., Prachayasittikul, V., & Tantimongcolwat, T. (2025). Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies. European Journal of Pharmaceutical Sciences, 204, 106961. https://doi.org/10.1016/j.ejps.2024.106961

Vancouver

Ayimbila F, Phopin K, Ruankham W, Pingaew R, Prachayasittikul S, Prachayasittikul V, et al. Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies. European Journal of Pharmaceutical Sciences. 2025;204:106961. doi:10.1016/j.ejps.2024.106961

BibTeX
@article{Ayimbila2025,
  author = {Ayimbila, Francis and Phopin, Kamonrat and Ruankham, Waralee and Pingaew, Ratchanok and Prachayasittikul, Supaluk and Prachayasittikul, Virapong and Tantimongcolwat, Tanawut},
  title = {Biophysical insight into the interaction mechanism of 4-bromo-N-(thiazol-2-yl)benzenesulfonamide and human serum albumin using multi-spectroscopic and computational studies},
  journal = {European Journal of Pharmaceutical Sciences},
  year = {2025},
  volume = {204},
  pages = {106961},
  doi = {10.1016/j.ejps.2024.106961}
}
Kostenlos starten →